Prediction model for early biochemical recurrence after radical prostatectomy based on the Cancer of the Prostate Risk Assessment score and the presence of secondary circulating prostate cells
Author:
Affiliation:
1. Hospital Carabineros of Chile; Nuñoa Chile
2. Faculty of Medicine; University Finis Terrae; Providencia Chile
3. Faculty of Medicine; Diego Portales University; Santiago Chile
4. Hospital DIPRECA; Las Condes Santiago Chile
Funder
Hospital de Carabineros de Chile
Publisher
Wiley
Subject
Urology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/bju.13367/fullpdf
Reference30 articles.
1. Cancer statistics;Jemal;2010 CA Cancer J Clin,2010
2. NCCN Clinical practice guidelines in oncology 2015: prostate cancer guidelines www.nccn.org
3. Five year biochemcial recurrence free survival for intermediate risk prostate cancer after radical prostatectomy, eternal beam radiation therapy or permanent seed implantation;Vassil;Urology,2010
4. Oncologic outcome after extraperitoneal laparoscopic radical prostatectomy: midterm follow up of 1115 procedures;Pul;Eur Urol,2010
5. Immediate versus deferred androgen deprivation treatment in patients with node positive prostate cancer after radical prostatectomy and pelvic lymphadenectomy;Messing;Lancet Oncol,2006
Cited by 11 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. The CAPRA-S score versus subtypes of minimal residual disease to predict biochemical failure after radical prostatectomy;ecancermedicalscience;2020-06-25
2. Combination possibility and deep learning model as clinical decision-aided approach for prostate cancer;Health Informatics Journal;2019-06-26
3. Minimal residual disease in prostate cancer patients after primary treatment: theoretical considerations, evidence and possible use in clinical management;Biological Research;2018-09-04
4. Contemporary approach to predict early biochemical recurrence after radical prostatectomy: update of the Walz nomogram;Prostate Cancer and Prostatic Diseases;2018-02-27
5. Utility of cell-free nucleic acid and circulating tumor cell analyses in prostate cancer;Asian Journal of Andrology;2018
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3